➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Indoco Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for INDOCO, and what generic and branded alternatives to INDOCO drugs are available?

INDOCO has ten approved drugs.

There is one tentative approval on INDOCO drugs.

Summary for Indoco
US Patents:0

Drugs and US Patents for Indoco

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Indoco ALLOPURINOL allopurinol TABLET;ORAL 204467-002 Jul 28, 2016 AB RX No No   Get Started Free   Get Started Free
Indoco RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 206153-001 Oct 4, 2019 AB RX No No   Get Started Free   Get Started Free
Indoco OLANZAPINE olanzapine TABLET;ORAL 206155-003 Jul 31, 2020 AB RX No No   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.